OpenURL Connection Search

Select item for more details and to access through your institution.

Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.
Published in:
2018
By:
- Maundrell, Adam;
- Keighley, Caitlin;
- Englert, Helen;
- Sutrave, Gaurav;
- Gottlieb, David;
- Bilmon, Ian;
- Webb, Cameron E.;
- Watts, Matthew R.;
- Min-Xia Wang;
- Pamphlett, Roger;
- Jennings, Zoe;
- Brammah, Susan;
- Stark, Damien;
- Wang, Min-Xia
Publication type:
journal article
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
Published in:
American Journal of Hematology, 2023, v. 98, n. 1, p. 159, doi. 10.1002/ajh.26594
By:
- Gottlieb, David J.;
- Sutrave, Gaurav;
- Jiang, Wei;
- Avdic, Selmir;
- Street, Janine A.;
- Simms, Renee;
- Clancy, Leighton E.;
- Antonenas, Vicki;
- Gloss, Brian S.;
- Bateman, Caroline;
- Bishop, David C.;
- Micklethwaite, Kenneth P.;
- Blyth, Emily
Publication type:
Article
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus.
Published in:
Current Hematologic Malignancy Reports, 2019, v. 14, n. 4, p. 247, doi. 10.1007/s11899-019-00521-z
By:
- Jiang, Wei;
- Withers, Barbara;
- Sutrave, Gaurav;
- Clancy, Leighton E.;
- Yong, Michelle I.;
- Blyth, Emily
Publication type:
Article
Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA‐mismatched allogeneic stem cell transplant using infusion of third‐party T cells from multiple donors in addition to antivirals, rituximab, and surgery.
Published in:
Transplant Infectious Disease, 2021, v. 23, n. 2, p. 1, doi. 10.1111/tid.13528
By:
- Di Ciaccio, Pietro R.;
- Avdic, Selmir;
- Sutrave, Gaurav;
- Clancy, Leighton;
- Withers, Barbara;
- Blyth, Emily;
- McLeod, Duncan;
- Gottlieb, David J.
Publication type:
Article

Found: 4

Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.

Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus.

Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA‐mismatched allogeneic stem cell transplant using infusion of third‐party T cells from multiple donors in addition to antivirals, rituximab, and surgery.